{"nctId":"NCT02685748","briefTitle":"Aspirin in Young Psychotic Patients","startDateStruct":{"date":"2017-07-20","type":"ACTUAL"},"conditions":["Psychosis","Acute Psychosis","Schizophrenia"],"count":60,"armGroups":[{"label":"Aspirin & pantoprazole","type":"EXPERIMENTAL","interventionNames":["Drug: Aspirin","Drug: Pantoprazole"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Aspirin","otherNames":["Acetylsalicylic acid"]},{"name":"Placebo","otherNames":["sugar pill"]},{"name":"Pantoprazole","otherNames":["Protonix","Controloc"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* 18 to 28 years of life\n* diagnostic categories from F 20 to F 29, according to ICD 10 (International Classification of Diseases Version 10) criteria\n* duration of illness ≤ 7 years\n\nExclusion Criteria:\n\n* Substance abuse\n* Primary cognitive impairment\n* Contraindications and special caution for acetylsalicylic acid and pantoprazole: hypersensitivity to aspirin and other NSAIDs or pantoprazole, ulcers, gastritis, pregnancy, haemophilia, bleeding disorders, gout, asthma, COPD (Chronic obstructive pulmonary disease), bronchospasm induced by NSAIDs, angioedema, urticaria, haemolytic anaemia, use of warfarin or methotrexate, diabetes, reduced function of liver and/or kidney, heart failure, surgical/dental intervention, interactions with certain psychotropic drugs","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"28 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Neurological Soft Signs","description":"Neurological soft signs were assessed with the Heidelberg Scale which consists of five subscales (motor coordination, integrative functions, complex motor tasks, orientation, hard signs) comprising 16 items (gait, tandem walking, right/left orientation, arm holding test, finger to nose test, Ozeretzki's test, diadochokinesis, pronation-supination, finger to thumb opposition, mirror movements, two point discrimination, graphaesthesia, face- hand test, stereognosis, fist- edge- palm test, speech and articulation).\n\nRatings are given on a 0-3 point scale (no/slight/moderate/marked abnormality, respectively) for all items except for tandem walking (0-1 point scale; 0: no/slight, 1: moderate/marked abnormality). Scale ranges: minimum- 0 (better outcome), maximum 46 points (worse outcome).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.96","spread":"1.670"},{"groupId":"OG001","value":"7.04","spread":"1.537"}]}]}]},{"type":"PRIMARY","title":"Psychopathology Symptoms Assessed by PANSS","description":"The Positive and Negative Syndrome Scale (PANSS) is 30 item scale used to evaluate the presence, absence and severity of Positive, Negative and General Psychopathology symptoms of schizophrenia. Ratings are given on a 1-7 point scale (1- absent, 2- minimal, 3- mild, 4- moderate, 5- moderate severe, 6- severe, 7- extreme). Patient can not score lower than 30 for the total PANSS score. Maximum score is 210.\n\nHigher scores mean a worse outcome.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"67.70","spread":"10.227"},{"groupId":"OG001","value":"71.32","spread":"6.549"}]}]}]},{"type":"SECONDARY","title":"Cognitive Assessment by MoCA Scale","description":"The Montreal Cognitive Assessment (MoCA) is a test used to detect cognitive decline. The MoCA test examines seven domains (executive/visuospatial function, naming, attention, language, abstraction, recall, and orientation) of cognitive function with a total of 11 questions with a maximum score of 30. A score of 26 or over is considered to be normal. A score of less than 26 indicates cognitive impairment (worse outcome). Minimal score is 0.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"27.63","spread":"1.282"},{"groupId":"OG001","value":"28.32","spread":"1.757"}]}]}]},{"type":"SECONDARY","title":"Marker of Inflammation: C-reactive Protein (CRP)","description":"A C-reactive protein (CRP) test measures the level of C-reactive protein - a protein made by liver and releases in bloodstream in response to inflammation. Levels below 5 milligrams per liter (mg/L) are usually considered normal or free from infections.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.080","spread":"2.5549"},{"groupId":"OG001","value":"4.363","spread":"8.417"}]}]}]},{"type":"SECONDARY","title":"Marker of Inflammation- White Blood Cells (WBC)","description":"A white blood cell (WBC) count is a test that measures the number of white blood cells in blood. A white blood cell count can detect infections within body. The normal white blood cell count ranges between 4,000 and 11,000 cells per microliter.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.252","spread":"1.528"},{"groupId":"OG001","value":"6.303","spread":"1.405"}]}]}]},{"type":"SECONDARY","title":"Cytokine Profile- Th1- Interferon Gamma (IFN-γ)","description":"Change of Interferon Gamma (IFN-γ) immune response","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"92.557","spread":"29.696"},{"groupId":"OG001","value":"85.507","spread":"18.420"}]}]}]},{"type":"SECONDARY","title":"Cytokine Profile- Th2-Interleukin 4 (IL4)","description":"Change of IL4 immune response","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"620.340","spread":"817.873"},{"groupId":"OG001","value":"460.042","spread":"133.44"}]}]}]},{"type":"SECONDARY","title":"Cytokine Profile- Type 17- Interleukin 17 (IL17)","description":"Change of IL17 immune response","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11.760","spread":"14.691"},{"groupId":"OG001","value":"13.255","spread":"10.809"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":28},"commonTop":[]}}}